Adlai Nortye (ANL) Non-Current Assets (2022 - 2025)
Adlai Nortye (ANL) reported Non-Current Assets of $7.5 million for Q4 2025, up 4.65% year-over-year from $7.2 million in Q4 2024, and up 14.81% on a QoQ basis from $6.6 million in Q2 2025.
Adlai Nortye (ANL) has 4 years of Non-Current Assets data on file, last reported at $7.5 million in Q4 2025.
- Quarterly Non-Current Assets rose 4.65% year-over-year to $7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (up 4.65% YoY) and the FY2025 annual result came in at $7.5 million, up 4.65% from the prior year.
- Non-Current Assets advanced to $7.5 million in Q4 2025 per ANL's latest filing, from $6.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $29.0 million in Q4 2023 and bottomed at $6.3 million in Q4 2022.
- The 4-year median for Non-Current Assets is $7.3 million (2024), against an average of $10.7 million.
- The widest annual swing landed in 2023, when Non-Current Assets jumped 360.88%; it then plunged 75.15% in 2024.
- Tracing ANL's Non-Current Assets over 4 years: stood at $6.3 million in 2022, then jumped by 360.88% to $29.0 million in 2023, then sank by 75.15% to $7.2 million in 2024, then grew by 4.65% to $7.5 million in 2025.
- Per Business Quant, the three latest ANL Non-Current Assets figures stand at $7.5 million (Q4 2025), $6.6 million (Q2 2025), and $7.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 22.66 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 7.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.54 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Dec 31, 2024 | 7.21 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Dec 31, 2023 | 28.99 Mn |
| Dec 31, 2022 | 6.29 Mn |